Clinical ResearchInterventional CardiologyRenal Function-Based Contrast Dosing to Define Safe Limits of Radiographic Contrast Media in Patients Undergoing Percutaneous Coronary Interventions
Key Words
Abbreviations and Acronyms
Cited by (0)
The BMC2 (Blue Cross Blue Shield of Michigan Cardiovascular Consortium) registry is funded by Blue Cross Blue Shield of Michigan (BCBSM) and Blue Care Network, with initial registry development funded by the BCBSM Foundation. The sponsor had no role in study design, analysis, or the decision to present or publish these findings. Dr. Gurm has received research funding from BCBSM and the National Institute of Health. Dr. Dixon has received research support from Abbott Vascular, Abiomed, and Infraredx. Dr. Share is employed by BCBSM. Dr. LaLonde is on the speakers' bureau for Abbott Vascular, Gilead Sciences, Pfizer, and GlaxoSmithKline; and has received research support from Medtronic. Dr. Moscucci has received research support from BCBSM in the past. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.